ELIGARD J Code: J9217

Drug & Product Overview

HCPCS Descriptor Leuprolide acetate (for depot suspension), 7.5 mg

HCPCS Added Date January 1, 1991

Manufacturer Multiple Manufacturers

Route of Administration Subcutaneous

Generic Status Multi-Source; Generic

Dosage Type Single-Dose

Dosage Form Injection, Suspension, Extended Release | Kit

About ELIGARD

Eligard is a medication aligned to the HCPCS J Code: J9217 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the subcutaneous route and manufactured by multiple companies.

According to CMS Drug Use Information: Leuprolide is used to treat advanced prostate cancer. It is not a cure. Most types of prostate cancer need the hormone testosterone to grow and spread. Leuprolide works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells and helps relieve symptoms such as painful/difficult urination. Talk to your doctor about the risks and benefits of treatment.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 16 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
00074-3346-03	Lupron Depot	AbbVie Inc.	3	Kit
62935-0223-05	Eligard	TOLMAR Inc.	3	Kit
62935-0227-10	Eligard	TOLMAR Inc.	3	22.5 MG / 0.375 ML
62935-0306-40	Eligard	TOLMAR Inc.	4	30 MG / 0.5 ML
62935-0461-50	Eligard	TOLMAR Inc.	6	45 MG / 0.375 ML
•••••-••••-•• Log in to view	ELIGARD
	ELIGARD
	ELIGARD

Login to view 11 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

ELIGARD Pricing & Reimbursement

J9217 Private Payer Reimbursement

$178.99 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

Leuprolide Acetate 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J1950	AbbVie	Leuprolide Acetate	Injection, leuprolide acetate (for depot suspension), per 3.75 mg
J1951	Tolmar Pharmaceuticals	Leuprolide Acetate	Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
J1952	Accord	Leuprolide Acetate	Leuprolide injectable, camcevi, 1 mg
J1954	Generic Code (Multiple Manufacturers)	Leuprolide Acetate	Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg
J9217	Generic Code (Multiple Manufacturers)	Leuprolide Acetate	Leuprolide acetate (for depot suspension), 7.5 mg

ELIGARD Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 11.63%

Avg. Days to File 7.5days

Avg. Days to Pay 20.6days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9217 claims analytics on FocalPoint →

ELIGARD CPT Administration Codes

CPT Code	Description
96402	Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic

JW / JZ modifiers apply

CMS has identified Eligard (J9217) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

ELIGARD Medically Unlikely Edits (MUE)

The most billing units of J9217 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 7.5 mg.

Practitioner Office & Hospital Outpatient

6 units / day

= 45 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

ELIGARD Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Advanced Prostate Cancer Advanced prostate cancer

Drug Class

Gonadotropin Releasing Hormone Receptor Agonist [EPC]Gonadotropin Releasing Hormone Receptor Agonists [MoA]

Frequently Asked Questions

Is there an available Eligard billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for ELIGARD.

Are there any available Eligard patient assistance programs?

Our team has not identified a manufacturer-published source of patient assistance information for ELIGARD.

Where can I find Eligard prescribing information?

ELIGARD prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →

Where can I find Eligard side effect information?

Our team has not yet identified a source of side effects information for ELIGARD. Please check back in a few weeks.

Does billing ELIGARD require JZ/JW wastage modifiers?

CMS has identified ELIGARD(J9217) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.